Cash Flow - Monte Rosa Therapeutics, Inc. (GLUE)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -22.80 | 42.00 | -43.80 | -92.47 | -59.36 | -23.05 | -6.17 |
| Cash flow from investing | -101.83 | -44.45 | 88.80 | -219.22 | -9.65 | -3.39 | -1.39 |
| Cash flow from financing | 30.35 | 98.89 | 27.49 | 20.47 | 377.56 | 60.06 | 15.00 |
| Change in cash | -94.28 | 96.44 | 72.49 | -291.22 | 308.55 | 33.62 | 7.44 |
Show Quarterly Cash Flow
Cash Flow - Monte Rosa Therapeutics, Inc. (GLUE)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -37.37 | -43.01 | 100.43 | -34.72 | -45.49 | 128.92 | -20.99 | -27.77 | -38.17 | 29.63 | -24.71 | -25.32 | -23.41 | -23.96 | -20.60 | -20.50 | -27.40 | -14.17 | -17.79 | -13.58 | -13.82 | -8.57 | -6.89 | -4.21 | -3.38 |
| Cash flow from investing | -261.00 | -65.07 | 38.14 | 25.32 | -100.23 | -30.90 | 37.75 | -61.16 | 9.85 | 14.30 | 35.63 | 18.55 | 20.33 | -53.94 | 29.49 | -14.25 | -180.52 | -3.05 | -1.69 | -2.70 | -2.22 | -1.19 | -0.93 | -1.26 | -0.01 |
| Cash flow from financing | 328.34 | 29.62 | 0.35 | 0.37 | 0.01 | 0.61 | 0.02 | 98.02 | 0.25 | 25.17 | 1.10 | 1.20 | 0.02 | 20.43 | -0.22 | 0.10 | 0.15 | -0.14 | 29.46 | 205.47 | 142.77 | -0.01 | 47.75 | 12.32 | 142.77 |
| Change in cash | 29.97 | -78.46 | 138.91 | -9.03 | -145.71 | 98.63 | 16.77 | 9.10 | -28.07 | 69.10 | 12.02 | -5.57 | -3.06 | -57.47 | 8.67 | -34.65 | -207.77 | -17.35 | 9.97 | 189.19 | 126.74 | -9.77 | 39.93 | 6.85 | 139.38 |